COVID-19 Quarantine Dramatically Affected Male Sexual Behavior: Is There a Possibility to Go Back to Normality?

COVID-19 erectile function sexual satisfaction sexual well-being

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
08 May 2022
Historique:
received: 15 03 2022
revised: 27 04 2022
accepted: 03 05 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 15 5 2022
Statut: epublish

Résumé

We performed a monocentric longitudinal study on sexually active male patients, from May 2021 to October 2021, with SARS-CoV-2 infection confirmed with a nasopharyngeal reverse transcriptase polymerase chain reaction (RT-PCR). The questionnaires were delivered by email. The study period was divided into the periods before getting tested (T1), during quarantine (T2), 1 month after a negative test (T3), and 3 months after a negative test (T4). All participants were invited to complete these questionnaires: 10- and 6-item questionnaires, a sexual distress schedule (SDS), and the international index of erectile function questionnaire of 15 items (IIEF-15). The primary endpoint was to evaluate the impact of quarantine on male sexual function (SF) during and after the SARS-CoV-2 infection. A total of 22 male patients met the inclusion criteria. The differences for both SDS and IIEF-15 scores, between T1−T2 (27 (IQR 24.0−32.2) vs. 37.5 (IQR 34.2−45.5), 45 (IQR 38.0−50.2) vs. 28.5 (IQR 19.5−38.0)), T2−T3 (37.5 (IQR 34.2−45.5) vs. 28 (IQR 24.0−31.0), and 28.5 (IQR 19.5−38.0) vs. 39.5 (IQR 35.5−44.2)) were statistically significant (p < 0.001), respectively. Moreover, between T1−T4, no statistically significant difference (p > 0.05) was recorded in both SDS (27 (IQR 24.0−32.2) vs. 26.5 (IQR 24−30.2)) and IIEF-15 (45 (IQR 38.0−50.2) vs. 28.5 (IQR 19.5−38.0)). In 20 patients (90.9%), SARS-CoV-2 had a huge impact on relationship and sexual life, but no patient attended a clinic for sexual difficulties. In conclusion quarantine has negatively influenced SF in infected patients; however, 3 months after the rRT-PCR negative test, a promising return to the preinfection SF values is observed.

Identifiants

pubmed: 35566771
pii: jcm11092645
doi: 10.3390/jcm11092645
pmc: PMC9100217
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Sex Med. 2020 Jul;17(7):1225-1228
pubmed: 32418751
Reprod Toxicol. 2021 Jan;99:65-70
pubmed: 33249233
Adv Virol. 2020 Dec 09;2020:8826943
pubmed: 33376490
Minerva Endocrinol. 2020 Jun;45(2):77-78
pubmed: 32270992
JAMA. 2020 May 12;323(18):1846-1848
pubmed: 32215581
Lancet. 2020 Nov 7;396(10261):1525-1534
pubmed: 32979936
J Sex Med. 2020 Jul;17(7):1222-1224
pubmed: 32487463
Sex Med Rev. 2017 Jul;5(3):349-364
pubmed: 28596070
Fertil Steril. 2020 Jun;113(6):1154
pubmed: 32387274
Urology. 1997 Jun;49(6):822-30
pubmed: 9187685
Int J Gynaecol Obstet. 2020 Jul;150(1):98-102
pubmed: 32392400
J Androl. 2007 Mar-Apr;28(2):223-8
pubmed: 17021333
Arch Sex Behav. 2018 Aug;47(6):1733-1743
pubmed: 29557994
New Sci. 2021 Dec 4;252(3363):7
pubmed: 34876769
JAMA Netw Open. 2020 May 1;3(5):e208292
pubmed: 32379329
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143

Auteurs

Lorenzo Spirito (L)

Department of Neurosciences, Reproductive Sciences, and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.

Michele Morelli (M)

Department of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
University of Milan, 20122 Milan, Italy.
Urology Unit, ASST Ospedale Manzoni, 23900 Lecco, Italy.

Roberto La Rocca (R)

Department of Neurosciences, Reproductive Sciences, and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.

Luigi Napolitano (L)

Department of Neurosciences, Reproductive Sciences, and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.

Claudia Collà Ruvolo (CC)

Department of Neurosciences, Reproductive Sciences, and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.

Lorenzo Romano (L)

Urology Unit, ASST Ospedale Manzoni, 23900 Lecco, Italy.

Angelo di Giovanni (A)

Department of Neurosciences, Reproductive Sciences, and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.

Carmine Sciorio (C)

Urology Unit, ASST Ospedale Manzoni, 23900 Lecco, Italy.

Sergio Concetti (S)

Urology Unit, Surgical Department, Azienda Usl, Maggiore-Bellaria Hospital, 40133 Bologna, Italy.

Emanuele Montanari (E)

Department of Urology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
University of Milan, 20122 Milan, Italy.

Francesca Tripodi (F)

Institute of Clinical Sexology, 00198 Rome, Italy.

Ferdinando Fusco (F)

Department of Neurosciences, Reproductive Sciences, and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.

Marco Capece (M)

Department of Neurosciences, Reproductive Sciences, and Odontostomatology, University of Naples "Federico II", 80131 Naples, Italy.

Classifications MeSH